Relafen 750, structurally known as diclofenac potassium, presents a compelling case from a biochemical perspective . Its mechanism of action primarily involves the blocking of cyclooxygenase catalysts , specifically COX-2, leading to a lessening in prostaglandin production . This process effectively reduces discomfort and swelling associated with m